(Q73307149)
Statements
Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage (English)
A V D'Amico
R Whittington
S B Malkowicz
D Schultz
A A Renshaw
J E Tomaszewski
J P Richie
1 December 1999